Back to results
CompletedPhase 3

Acetyl-L-Carnitine in Type 2 Diabetes

NCT00984750

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Hospital "Azienda Ospedaliera Ospedali Riunitidi Bergamo" Unit of Diabetology

Bergamo, Bergamo, Italy

+4 additional locations

View on ClinicalTrials.gov
Acetyl-L-Carnitine in Type 2 Diabetes — TrialFind